Air Products Chemicals Inc
For the period ended Sep 30, 2024. Filed Nov 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Nov 21, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Earnings Per Share
- EARNINGS PER SHARE
The table below details the computation of basic and diluted earnings per share ("EPS"):
| Fiscal Year Ended 30 September | 2024 | 2023 | 2022 |
|---|---|---|---|
| Numerator | |||
| Net income from continuing operations | $3,842.1 | $2,292.8 | $2,243.5 |
| Net (loss) income from discontinued operations | (13.9) | 7.4 | 12.6 |
| Net Income attributable to Air Products | $3,828.2 | $2,300.2 | $2,256.1 |
| Denominator (in millions) | |||
| Weighted average common shares — Basic | 222.5 | 222.3 | 222.0 |
| Effect of dilutive securities | |||
| Employee stock option and other award plans | 0.3 | 0.4 | 0.5 |
| Weighted average common shares — Diluted | 222.8 | 222.7 | 222.5 |
| Per Share Data(A) (U.S. Dollars per share) | |||
| Basic EPS from continuing operations | $17.27 | $10.31 | $10.11 |
| Basic EPS from discontinued operations | (0.06) | 0.03 | 0.06 |
| Basic EPS attributable to Air Products | $17.21 | $10.35 | $10.16 |
| Diluted EPS from continuing operations | $17.24 | $10.30 | $10.08 |
| Diluted EPS from discontinued operations | (0.06) | 0.03 | 0.06 |
| Diluted EPS attributable to Air Products | $17.18 | $10.33 | $10.14 |
(A)EPS is calculated independently for each component and may not sum to total EPS due to rounding.
Diluted EPS attributable to Air Products reflects the potential dilution that could occur if stock options or other share-based awards were exercised or converted into common stock. The dilutive effect is computed using the treasury stock method, which assumes all share-based awards are exercised, and the hypothetical proceeds from exercise are used by the Company to purchase common stock at the average market price during the period. To the extent they would have been dilutive, the incremental shares, or the difference between shares assumed to be issued versus purchased, are included in the denominator of the diluted EPS calculation. Antidilutive outstanding share-based awards were not material in fiscal years 2024, 2023 and 2022.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.